Document is current
Any future updates will be listed below
-
Authors
Artime, Esther
Zimner-Rapuch, Sarah
Chen, Roger
Ji, Qiuhe
Tatsuno, Ichiro
Newson, Rachel S.
Shingaki, Tomotaka
Si, Si
Kewley, Rachel
Riley, Sam
Khare, Swarna
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 17 March 2025
Accepted: 17 July 2025
First Online: 1 August 2025
Declarations
:
: This study was funded by Eli Lilly. Esther Artime, Tomotaka Shingaki, Sarah Zimner-Rapuch and Si Si are employees of Eli Lilly and may hold stock or stock options. Rachel S Newson is an employee of Eli Lilly and is a minor shareholder. Swarna Khare was an employee of Eli Lilly at the time of the study and is a current employee of Novartis. Rachel Kewley and Sam Riley are employees of Adelphi Values PROVE; Adelphi Values PROVE received payment from Eli Lilly for the conduct of this study. Roger Chen, Qiuhe Ji and Ichiro Tatsuno have no conflicts of interest to declare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
